FIIs can invest up to 40% in Shilpa Medicare

30 May 2017 Evaluate

Reserve Bank of India (RBI) has notified that Foreign Institutional Investors (FIIs)/ Foreign Portfolio Investors (FPIs) can now invest from 30% to 40% of the paid up capital of Shilpa Medicare under the Portfolio Investment Scheme (PIS). The company has passed resolutions at its Board of Directors' level and a special resolution by general body agreeing for enhancing the FII/FPI investment limit under Portfolio Investment Scheme up to 40% of the paid up capital of the company.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

300.20 13.00 (4.53%)
03-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1702.80
Dr. Reddys Lab 1235.00
Cipla 1322.45
Zydus Lifesciences 902.95
Lupin 2186.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×